...
首页> 外文期刊>Immunology: An Official Journal of the British Society for Immunology >Peroxisome proliferator activated receptor gamma is not necessary for the development of LPS-induced tolerance in macrophages.
【24h】

Peroxisome proliferator activated receptor gamma is not necessary for the development of LPS-induced tolerance in macrophages.

机译:过氧化物酶体增殖物激活的受体γ对于巨噬细胞中LPS诱导的耐受性的发展不是必需的。

获取原文
获取原文并翻译 | 示例
           

摘要

Peroxisome proliferator activated receptor-gamma (PPARgamma) has been reported to exert anti-inflammatory properties in endotoxic shock and sepsis. One phenomenon that alters the inflammatory response to endotoxin [lipopolysaccharide (LPS)] is endotoxin tolerance, which is caused by previous exposure to endotoxin. Here, we investigate whether changes in endogenous PPARgamma function regulate this phenomenon using three different models of LPS-induced tolerance in macrophages. In a first in vitro model, previous LPS exposure of murine J774.2 macrophages suppressed tumour necrosis factor-alpha (TNF-alpha) release in response to subsequent LPS challenge. Treatment of J774.2 cells with the PPARgamma inhibitor GW9662 did not alter tolerance induction because these cells were still hyporesponsive to the secondary LPS challenge. In a second ex vivo model, primary rat peritoneal macrophages from LPS-primed rats exhibited suppression of thromboxane B2 and TNF-alpha production, while maintaining nitrite production in response to in vitro LPS challenge. Pretreatment of rats with the PPARgamma inhibitor GW9662 in vivo failed to alter the tolerant phenotype of these primary macrophages. In a third ex vivo model, primary peritoneal macrophages with conditional deletion of PPARgamma were harvested from LPS-primed Cre-lox mice (Cre+/+ PPARgamma-/-) and exhibited significant suppression of TNF-alpha production in response to in vitro LPS challenge. Furthermore, both LPS-primed PPARgamma-deficient Cre+/+ PPARgamma-/- mice and wild-type Cre-/- PPARgamma+/+ mice exhibited reduced plasma TNF-alpha levels in response to a high dose of LPS in vivo. These data demonstrate that PPARgamma does not play a role in the LPS-induced tolerant phenotype in macrophages.
机译:据报道,过氧化物酶体增殖物激活受体-γ(PPARγ)在内毒素性休克和败血症中发挥抗炎作用。改变对内毒素[脂多糖(LPS)]的炎症反应的一种现象是内毒素耐受性,这是由先前接触内毒素引起的。在这里,我们调查内源性PPARγ功能的变化是否使用LPS诱导的巨噬细胞耐受性的三种不同模型来调节这种现象。在第一个体外模型中,先前对鼠J774.2巨噬细胞的LPS暴露抑制了肿瘤坏死因子-α(TNF-alpha)释放,以响应随后的LPS攻击。用PPARγ抑制剂GW9662处理J774.2细胞不会改变耐受诱导,因为这些细胞仍然对次级LPS攻击反应不足。在第二个离体模型中,来自LPS致敏大鼠的原代大鼠腹膜巨噬细胞显示出血栓烷B2和TNF-α产生的抑制作用,同时响应体外LPS攻击而保持亚硝酸盐产生。在体内用PPARγ抑制剂GW9662预处理大鼠未能改变这些原代巨噬细胞的耐受表型。在第三个离体模型中,从LPS引发的Cre-lox小鼠(Cre + / + PPARgamma-/-)收获具有条件性PPARγ缺失的原发性腹膜巨噬细胞,并显示出对体外LPS刺激的TNF-α产生的显着抑制。 。此外,LPS引发的PPARγ缺陷Cre + / +PPARγ-/-小鼠和野生型Cre-/-PPARγ+ / +小鼠在体内对高剂量LPS​​的反应均显示血浆TNF-α水平降低。这些数据表明,PPARγ在巨噬细胞的LPS诱导的耐受表型中不起作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号